| Name | (-)-Emtricitabine-¹³C,¹⁵N2 |
|---|---|
| Synonyms |
4-Amino-5-fluoro-1-[(2R,5S)-2-hydroxymethyl)-1,3-oxathiolan-5-yl]-2-(1H-pyrimidinone-13C,15N2
BW 1592-13C,15N2 BW 524W91-13C,15N2 Coviracil-13C,15N2 2(1H)-Pyrimidinone-2-13C-1,3-15N2, 4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]- (-)-2'-Deoxy-5-fluoro-3'-thiacytidine-13C,15N2 4-Amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-(2-13C,15N2)pyrimidinone (-)-2',3'-Dideoxy-5-fluoro-3'-thiacytidine-13C,15N2 |
| Description | Emtricitabine-13C,15N2 (BW1592-13C,15N2) is a 13C- and 15N-labeled Emtricitabine (HY-17427). Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) with an EC50 of 0.01 μM in PBMC cell. It is an antiviral agent for the treatment of HIV infection. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.8±0.1 g/cm3 |
|---|---|
| Melting Point | >145° C (dec.) |
| Molecular Formula | C713CH10FN15N2O3S |
| Molecular Weight | 250.23 |
| Exact Mass | 250.040115 |
| Index of Refraction | 1.731 |
| Water Solubility | Soluble in Ether and Methanol |